Related Experiment Videos
Dynamics of HTLV-1 leukemogenesis: data acquisition for computer modeling
Gerhard R F Krueger1, Michael E Brandt, Guanyu Wang
1Department of Pathology & Laboratory Medicine, UT-Houston Medical School, 6431 Fannin St., MSB 2.246, Houston, Texas 77030, USA. Gerhard.Kruegerauth.tmc.edu
In Vivo (Athens, Greece)
|June 21, 2002
Summary
Human T-lymphotropic virus type 1 (HTLV-1) causes adult T-cell leukemia (ATL) by altering CD4+ cell apoptosis and proliferation. This dysregulative leukemogenesis provides a model for computer simulations.
Area of Science:
- Virology
- Immunology
- Oncology
Background:
- Human T-lymphotropic virus type 1 (HTLV-1) establishes a lifelong infection.
- HTLV-1 primarily infects CD4+ T-lymphocytes, the same cells targeted by HIV and HHV-6.
- A significant latency period precedes the development of adult T-cell leukemia (ATL).
Purpose of the Study:
- To analyze HTLV-1 virus load, apoptosis, and leukocyte changes during ATL development.
- To compare HTLV-1 pathogenesis with HHV-6 and HIV infections for computational modeling.
- To understand the mechanisms of HTLV-1-induced leukemogenesis.
Main Methods:
- Literature search of 1003 publications on HTLV-1 and ATL.
- Evaluation of data on virus load, apoptosis, and peripheral blood leukocyte changes.
- Comparative analysis with existing data on HHV-6 and HIV infections.
Main Results:
- HTLV-1 exhibits a long latent phase with low provirus copy numbers in CD4+ cells.
- Viral replication and provirus copy numbers increase as immune surveillance declines.
- Apoptosis of infected lymphocytes decreases with rising viral load, promoting proliferation.
Conclusions:
- HTLV-1 infection leads to dysregulated leukemogenesis, characterized by altered lymphocyte populations.
- The progression involves a shift towards immature cells in peripheral blood.
- HTLV-1-induced ATL pathogenesis is suitable for validating computer simulation models.